Objective: To test the hypothesis that inhibition of CaMKII-phosphorylated type-2 ryanodine receptors (RyR2) prevents AF initiation in FKBP12.6-deficient (؊/؊) mice. 
A trial fibrillation (AF) is the most prevalent sustained arrhythmia and is associated with extensive morbidity and mortality. 1 Defects in intracellular Ca 2ϩ handling may directly contribute to pathogenic mechanisms underlying AF, such as ectopic activity and reentry. 2 Previous studies revealed a higher open probability of type-2 ryanodine receptors (RyR2) isolated from dogs with chronic AF. 3 This has been attributed to increased S2808 phosphorylation on RyR2 by protein kinase A, 3 decreased levels of FK506-binding protein 12.6 (FKBP12.6) binding to RyR2, 3 and increased Ca 2ϩ /calmodulin-dependent protein kinase II (CaMKII) phosphorylation of RyR2 at S2814. 4 Whereas CaMKII inhibition might suppress aberrant sarcoplasmic reticulum (SR) Ca 2ϩ release events associated with AF, 4, 5 it remains unknown whether phosphorylation of S2808 and/or S2814 play a causal role in AF induction. Moreover, it is unknown whether SR Ca 2ϩ leak and spontaneous Ca 2ϩ waves (SCaWs) through RyR2 generate Na ϩ /Ca 2ϩ -exchanger (NCX) current sufficiently large to cause delayed afterdepolarizations (DADs) and triggered action potentials (APs). We tested the hypothesis that genetic inhibition of RyR2 phosphorylation at S2808 and/or S2814 phosphorylation sites prevents AF induction in FKBP12.6-deficient (FKBP12.6Ϫ/Ϫ) mouse model of AF 6 and assessed the underlying mechanisms at the cellular, organ, and whole-animal level.
Methods
An expanded Methods section is available in the Data Supplement at http://circres.ahajournals.org. All animal studies were performed in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health. To test the consequences of inhibition of RyR2 phosphorylation at S2814 on Ca 2ϩ release and arrhythmogenesis, we intercrossed FKBP12.6Ϫ/Ϫ mice with S2814A knock-in mice. 4 In vivo electrophysiology was performed as previously described. 4, 6 Ca 2ϩ imaging and patch-clamp studies were conducted in isolated atrial myocytes. 4, 6 Original received July 22, 2011; revision received November 23, 2011; accepted November 28, 2011. In October 2011, the average time from submission to first decision for all original research papers submitted to Circulation Research was 15 days.
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FKBP12.6 Deficiency Promotes Triggered Activity in Mouse Atria
To determine whether FKBP12.6 deficiency can cause atrial arrhythmias at the tissue level, optical mapping of isolated atria was performed. Figure 1 shows representative optical APs recorded at 3 sites in an FKBP12.6Ϫ/Ϫ mouse atrium during a spontaneous atrial tachyarrhythmia. Voltage mapping revealed fragmented activation as evidenced by an area of rapid activation or potential "driver" (Site 1: cycle lengthϭ80 ms) compared with areas of variable activation (Site 2: variable voltage amplitude) and 2:1 activation (Site 3: cycle lengthϭ160 ms) ( Figure 1A ). The incidence of spontaneous AF and atrial flutter was higher in FKBP12.6Ϫ/Ϫ mice compared with wild-type (WT) mice (PϽ0.05, Figure  1A ). This suggests that atria from FKBP12.6Ϫ/Ϫ mice are susceptible to spontaneous arrhythmias, which arise from a focal source driving the remaining atrium. Localized diastolic Ca 2ϩ release may produce DADs and triggered beats in intact tissue. 7 (Figure 2A ). There was no difference in full-duration of half-maximum of Ca 2ϩ sparks among the 3 genotypes ( Figure 2B ), whereas there was a small decrease in full-width of half-maximum in FKBP12.6Ϫ/Ϫ:S2814A mice ( Figure 2C) Figure 2D ).
Recent studies suggest that a fraction of SR Ca 2ϩ leak is not detectable as Ca 2ϩ sparks. 8 Therefore, total SR Ca 2ϩ leak was also measured using the tetracaine protocol (Online Figure I ). The ratio of SR Ca 2ϩ leak to SR Ca 2ϩ load was significantly larger in FKBP12.6Ϫ/Ϫ mice compared with WT (11.8Ϯ0.8 versus 5.8Ϯ0.8%; PϽ0.001; Online Figure  I ). 6 Conversely, SR Ca 2ϩ leak was reduced in FKBP12.6Ϫ/Ϫ: S2814A myocytes to levels seen in WT mice (5.9Ϯ0.4%; PϽ0.05), suggesting that prevention of RyR2 phosphorylation at S2814 was sufficient to reverse abnormal SR Ca 2ϩ leak in FKBP12.6Ϫ/Ϫ myocytes.
DADs in FKBP12.6؊/؊ Mice Depend on CaMKII Phosphorylation of RyR2
Next, we measured membrane potentials in myocytes from WT, FKBP12.6Ϫ/Ϫ and FKBP12.6:S2814A mice at 3 Hz (Figure 3 ). Mean AP durations at 30% and 50% repolarization (APD 30 and APD 50 , respectively) were similar in the 3 genotypes (APD 30 and APD 50 : 3.7Ϯ0.9; 9.9Ϯ1.9 ms in WT, 4.5Ϯ0.9; 11.9Ϯ2.3 ms in FKBP12.6Ϫ/Ϫ, 4.7Ϯ0.5; 10.2Ϯ0.9 ms in FKBP12.6Ϫ/Ϫ:S2814A). Whereas WT myocytes typically showed pacing-induced APs only, we observed frequent nonpaced (spontaneous) APs ( Figure 3A ) and/or DADs ( Figure 3B ) in FKBP12.6Ϫ/Ϫ myocytes. In fact, 73% (8 of 11) cells from FKBP12.6Ϫ/Ϫ mice developed DADs, whereas only 16.7% (1 of 6) of WT myocytes showed this behavior (PϽ0.05). In contrast, incidence of DADs was significantly reduced to 25% (4 of 16) in FKBP12.6Ϫ/Ϫ: S2814A myocytes (PϽ0.05 versus FKBP12.6Ϫ/Ϫ; Figure  3C ). Finally, simultaneous recordings of Ca 2ϩ transients and membrane voltage, or Ca 2ϩ transients and membrane current in FKBP12.6:S2814A myocytes under the same conditions as in Figure 1B and 1C, revealed significantly reduced incidence of SCaW-induced DADs and SCaW-induced I NCX in FKBP12.6Ϫ/Ϫ:S2814A compared with FKBP12.6Ϫ/Ϫ myocytes (Online Figure II) . Thus, inhibition of S2814 phosphorylation on RyR2 prevents triggered activity in FKBP12.6Ϫ/Ϫ mice myocytes.
Inhibition of CaMKII Phosphorylation of RyR2 Prevents AF Induction in FKBP12.6؊/؊ Mice
We also determined whether inhibition of CaMKII phosphorylation of RyR2 could prevent AF induction in FKBP12.6Ϫ/Ϫ mice. We found that 53% (10 of 19) of FKBP12.6Ϫ/Ϫ mice developed AF/atrial flutter after atrial burst pacing, compared with 13% (2 of 15) of WT mice ( Figure 4A ). 
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Mechanisms of AF in FKBP12.6؊/؊ mice 3 tion of S2814 in FKBP12.6:S2814A significantly decreased the number of inducible AF episodes to 0.55Ϯ0.16 (PϽ0.01). Inactivation of phosphorylation sites on RyR2 did not alter baseline electrophysiological and conduction properties (Online Table I ). Finally, the importance of the S2814 phosphorylation site was confirmed in a second mouse model of RyR2 dysfunction previously associated with an elevated propensity toward AF as a result of heterozygosity for mutation R176Q in RyR2 (R176Q/ϩ mice) 4 (Online Figure III) .
Rapid Atrial Pacing Leads to CaMKII Activation and Phosphorylation of RyR2 and Phospholamban
To gain more insight into the mechanisms underlying induction of AF after rapid atrial pacing, we determined whether the CaMKII was activated in atria of paced mice (Online Figure IV. ). There were no differences in CaMKII expression or the level of CaMKII-T287 autophosphorylation at baseline among the different genotypes. After atrial burst pacing, activation of CaMKII (evidenced by increased CaMKII-T287 autophosphorylation) resulted in enhanced phosphorylation of both RyR2 at S2814 and phospholamban at T17 (Online Figure IV ). There were no differences in S2808 phosphorylation on RyR2 and S16 on phospholamban before and after pacing (Online Figure V) . Finally, protein expression levels of sarco/endoplasmic reticulum Ca 2ϩ -ATPase-2a (SERCA2a) and NCX were similar among all 4 genotypes (Online Figure V) , suggesting that RyR2 mutations at S2808A and S2814A did not cause compensatory remodeling of SR Ca 2ϩ -handling proteins.
Discussion
Studies over the past decade have demonstrated that SR Ca 2ϩ release is abnormal in patients with chronic AF. 2 Whereas the amplitude of the L-type Ca 2ϩ current is generally decreased in AF, Ca 2ϩ leak through RyR2 is typically elevated despite similar or decreased SR Ca 2ϩ contents. 2, 5 It has been proposed that triggered activity due to DADs is caused by an inward depolarizing I NCX current, which occurs in response to the removal of excess Ca 2ϩ release from the cytosol. 9, 10 We provide direct experimental evidence for this mechanism in the FKBP12.6Ϫ/Ϫ mouse model of AF. Our data revealed that FKBP12.6Ϫ/Ϫ mice exhibit atrial focal activity and AF caused by SR Ca 2ϩ leak, NCX activation, and DADs generation. Because recent studies revealed that CaMKII phosphorylation of RyR2 at S2814 is elevated in patients with chronic AF, 4, 5 we investigated whether inhibition of S2814 phosphorylation of RyR2 affected susceptibility of FKBP12.6Ϫ/Ϫ to AF. Our results demonstrate that inhibition of S2814 but not S2808 phosphorylation suppressed pacing-induced AF in FKBP12.6Ϫ/Ϫ mice by preventing spontaneous SCaWs and related DADs. Therefore, our studies suggest that elevated CaMKII phosphorylation on RyR2 might be the primary phosphorylation event associated with triggered activity and AF induction, 2 at least in the particular mutant mice examined in this study. These data are consistent with evidence showing that expression levels and activity of cytosolic CaMKII are upregulated in patients with chronic AF. 4, 5 Elevated CaMKII activity not only leads to increased RyR2 phosphorylation at S2814 but also causes increased phospholamban phosphorylation at T17, which might help preserve SR Ca 2ϩ content in AF 11 by increasing SR Ca 2ϩ uptake through SERCA2a disinhibition. We demonstrated that (partial) inhibition of S2814 phosphorylation on RyR2 is sufficient to suppress inducibility of AF after atrial burst pacing in R176Q/ϩ:S2814A/ϩ mice. Whereas this suggests that CaMKII phosphorylation of RyR2 contributes to SR Ca 2ϩ leak associated with arrhythmogenesis, this did not exclude the possibility that CaMKII phosphorylation of phospholamban or other ion channels/transporters also contribute under some circumstances.
In conclusion, our data demonstrate that an increase in CaMKII phosphorylation of RyR2 at S2814 contributes to AF initiation in FKBP12.6Ϫ/Ϫ mice by amplifying SR Ca 2ϩ leak and inducing DADs. Conversely, inhibition of CaMKII phosphorylation of RyR2 prevents AF initiation by decreasing aberrant SR Ca 2ϩ release, NCX activation, and DADs generation, whereas inhibition of S2808 phosphorylation of RyR2 failed to prevent AF induction. Together, our findings imply that CaMKII phosphorylation of S2814 on RyR2 might play an important role in enhancing RyR2-mediated SR Ca 2ϩ leak that promotes DADs and atrial triggered activity associated with AF. 
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Novelty and Significance
What Is Known?
• Atrial fibrillation (AF) is the most prevalent sustained cardiac arrhythmia.
• Increased open probability of ryanodine receptors (RyR2) contributes to defective intracellular Ca 2ϩ handling in AF.
• Ca 2ϩ /calmodulin-dependent kinase II (CaMKII) is upregulated in patients with chronic AF.
What New Information Does This Article Contribute?
• Genetic inhibition of CaMKII phosphorylation of RyR2 prevents induction of AF in FKBP12.6-deficient mice.
• CaMKII phosphorylation of RyR2 promotes spontaneous Ca 2ϩ waves, activation of inward Na ϩ /Ca 2ϩ exchange current, and delayed afterdepolarizations in atrial myocytes from FKBP12.6-deficient mice.
Previous studies demonstrated higher open probability of RyR2 in patients with chronic AF. Biochemical studies revealed increased phosphorylation levels of serine 2808 and serine 2814 on RyR2, as well as increased CaMKII activity. We present evidence that inhibition of serine 2814 but not serine 2808 prevents induction of AF in the FKBP12.6-deficient mouse model of AF. Atrial myocytes from FKBP12.6-deficient mice exhibited spontaneous Ca 2ϩ waves (SCaWs) leading to Na ϩ /Ca 2ϩ -exchange current activation and delayed afterdepolarizations. We therefore conclude that serine 2814 is an important downstream target of CaMKII in atrial fibrillation. We propose that defective sarcoplasmic reticulum calcium release through hyperphosphorylated RyR2 may cause triggered activity in atria and contribute to the initiation of AF. Our findings suggest that inhibition of CaMKII phosphorylation of RyR2 could be a potential target for AF treatment. 1, 2 RyR2-S2814A knock-in mice (S2814A) were generated as previously described. 3 Serine2814 on RyR2 was substituted with alanine, which inhibits CaMKII phosphorylation of S2814 on RyR2. S2808A knock-in mice were generously provided by Dr.
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Andrew Marks (Columbia University, NY). 4, 5 Serine2808 on RyR2 was substituted with alanine such that PKA phosphorylation of S2808 on RyR2 was inhibited. FKBP12.6 deficient (-/-) and R176Q/+ mice were intercrossed with S2814A and S2808A mice, to obtain FKBP12.6-/-:S2814A or FKBP12.6-/-:S2808A mice, respectively. These mice were used for electrophysiology, biochemistry, Ca 2+ imaging and patch clamp studies. S2814A and S2808A mice were also intercrossed with R176Q/+ mice to compound heterozygous R176Q/+:S2814A/+ or R176Q/+:S2808A/+ mice, respectively. All animals were studied at age of 3-4 month.
Optical mapping of intact atria. Whole atria electrophysiological studies were performed in WT (n=6) and FKBP12.6-/-(n=7) mice. Briefly, isolated hearts were Langendorff perfused with oxygenated Tyrode's solution and the voltage sensitive dye di-4-ANEPPS (4 mmol/ l). After 5-7
min of Langendorff perfusion the L and R atria were carefully dissected away from the ventricles and placed in a microscope imaging chamber for optical mapping. All preparations were 2 continuously superfused with normal Tyrode's solution at 37°C. Voltage dye fluorescence intensity was measured using a high-speed CCD camera that is attached to the microscope imaging system. Spontaneous atrial arrhythmias were defined as any atrial tachyarrhythmia lasting >30 s that developed during a 5 min period of electrophysiological monitoring without external pacing. Statistical differences were assessed with the Chi Square test.
In vivo electrophysiology in mice. Briefly, atrial and ventricular intracardiac electrograms were recorded using an 1.1F octapolar catheter (EPR-800, Millar Instruments, Houston, Texas)
inserted via the right jugular vein. Surface and intracardiac electrophysiology parameters were assessed at baseline. Right atrial pacing was performed using 2-ms current pulses delivered by an external stimulator (STG-3008, Multi Channel Systems, Reutlingen, Germany). Sinus node recovery time (SNRT) was measured after applying a 15-s atrial pacing train at a basic cycle length of 100 ms. SNRT is defined as the interval between the last stimulus of the pacing train and the onset of first spontaneous sinus beat. Atrial effective refractory period (AERP) and the effective refractory period of the atrioventricular effective refractory period (AVERP) were determined by applying a series of atrial pacing trains at a fixed basic cycle length of 100 ms (S1) with a S2 premature stimulus. The S1-S2 interval was progressively reduced by 2-ms in each pacing train from 70ms to 20ms. The AERP is defined as the longest S1-S2 coupling interval for atria that failed to generate a propagated beat with S2. The AVERP is defined as the longest S1-S2 coupling interval at which the premature stimulation delivered to the atrium is followed by a His potential but not by a QRS complex. Atrial fibrillation (AF) inducibility was determined by using the protocol described by Sood et al., 6 and defined as the occurrence of rapid and fragmented atrial electrograms with irregular AV-nodal conduction and ventricular rhythm for at least 1 second. Inducibility of AF was considered positive if at least 2 of 3 pacing trials induced AF 3 .
3
Western blot analysis Protein extraction and Western blotting was performed as previously (Rockland Immunochemicals), respectively, and bands were quantified using Image J.
Atrial Myocyte Isolation.
Mouse atrial myocytes were isolated as described previously. 3 Briefly, the heart was removed and the blood was washed out with 0 Ca 2+ Tyrode solution (137 mM NaCl, 5.4 mM KCl, 1 mM MgCl 2 , 5 mM HEPES, 10 mM glucose, 3 mM NaOH, pH 7.4). The heart was cannulated through the aorta and perfused on a Langendorff apparatus with 0 Ca Table   Online Table I 
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